- Home
- / Allarity Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Allarity Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.5
2024-10-29
Market Capitalization
$2.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| DKK | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 2.1M | 801.0K | |
| Gross profit | 9.5M | 2.9M | 145.0K |
| Gross profit margin, % | 443.3% | 362.2% | |
| Operating expense total | 41.8M | 69.4M | 59.1M |
| Depreciation and amortization | 213.0K | 81.6M | 1.1M |
| EBITDA | (24.4M) | (66.5M) | (59.0M) |
| EBITDA margin, % | -1136.6% | -8302.4% | |
| EBIT | (24.6M) | (148.1M) | (60.0M) |
| EBIT margin, % | -1146.5% | -18489.6% | |
| Interest income | 534.0K | 48.0K | |
| Interest expense | 1.9M | 26.6M | 4.4M |
| Pre tax profit | (22.5M) | (174.9M) | (59.1M) |
| Income tax expense | (7.0M) | (36.8M) | (11.4M) |
| Net Income | (15.5M) | (138.1M) | (47.7M) |